Are COVID-19 Vaccines Safe and Effective?
Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
Topical steroid withdrawal diagnostic criteria defined by researchers
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...
LAist1d
NIH cuts funding for vaccine-hesitancy research. mRNA research may be next
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
Medscape3d
Omalizumab vs Oral Immunotherapy: No Clear Winner
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
Science Daily7d
Research identifies key antibodies for development of broadly protective norovirus vaccine
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...
Breakthrough Treatment Helps Food Allergy Sufferers Tolerate More Allergens
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
Guarded N.I.H. Nominee Faces Sharp Questions on Vaccines and Research Cuts
Dr. Jay Bhattacharya, a professor of medicine at Stanford University, gained prominence during the Covid pandemic when he ...
NIH director nominee outlines his goals to improve public health
A relatively sedate Senate Health, Education, Labor and Pensions Committee confirmation hearing for National Institutes of Health Director-nominee Dr. Jay Bhattacharya revealed his five goals to ...
Scientific American10d
On COVID’s Fifth Anniversary, Scientists Reflect on Mistakes and Successes
Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...